Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 24, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784)…
August 24, 2026
Amart Furniture to Overhaul Forecasting and Replenishment with RELEX
Australia’s leading furniture retailer replaces legacy planning tools with…
August 24, 2026
Inspira Enterprise Expands into Australia to Accelerate AI-Driven Cybersecurity and Digital Resilience Across Enterprises
SYDNEY, Aug. 24, 2026 /PRNewswire/ — Inspira Enterprise, a global leader in…